PhaseBio Pharmaceuticals, Inc. (PHAS)
Total Liabilities
$139.56M
Quarterly · Period ending: · USD
PHAS Total Liabilities
Latest reported$139.56Mperiod ending
Latest reported$139.56Mperiod ending
PHAS Quarterly Total Liabilities ($111.52M → $139.56M)
Quarterly total liabilities
High-resolution chart · PNG
PHAS total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 139,564,000 | |
| 141,059,000 | |
| 153,574,000 | |
| 128,054,000 | |
| 119,812,000 | |
| 92,410,000 | |
| 75,559,000 | |
| 53,855,000 | |
| 44,417,000 | |
| 23,372,000 | |
| 22,516,000 | |
| 15,399,000 | |
| 15,829,000 | |
| 12,304,000 | |
| 12,099,000 | |
| 143,662,000 | |
| 9,247,000 | |
| 111,515,000 |